
1. malar j. 2015 jul 8;14:264. doi: 10.1186/s12936-015-0783-3.

identification large variation pfcrt, pfmdr-1 pfubp-1 markers in
plasmodium falciparum isolates ethiopia tanzania.

golassa l(1)(2), kamugisha e(3), ishengoma ds(4), baraka v(5)(6), shayo a(7),
baliraine fn(8), enweji n(9), erko b(10), aseffa a(11), choy a(12), swedberg
g(13).

author information: 
(1)aklilu lemma institute pathobiology, addis ababa university, addis ababa,
ethiopia. lgolassa@gmail.com.
(2)armauer hansen research institute, addis ababa, ethiopia. lgolassa@gmail.com.
(3)department biochemistry, catholic university health allied
sciences-bugando, mwanza, tanzania. erasmuskamugisha@yahoo.com.
(4)national institute medical research, tanga, tanzania. deusishe@yahoo.com.
(5)national institute medical research, tanga, tanzania.
vitobaraka@gmail.com.
(6)international health unit, department epidemiology, university antwerp, 
antwerp, belgium. vitobaraka@gmail.com.
(7)the nelson mandela african institution science technology, arusha,
tanzania. alex.shayo@mail.com.
(8)department biology, letourneau university, longview, tx, usa.
fredbaliraine@letu.edu.
(9)department medical biochemistry microbiology, uppsala university,
uppsala, sweden. nizar.enweji@imbim.uu.se.
(10)aklilu lemma institute pathobiology, addis ababa university, addis ababa, 
ethiopia. be7roro@gmail.com.
(11)armauer hansen research institute, addis ababa, ethiopia. aseffaa@gmail.com.
(12)department medical biochemistry microbiology, uppsala university,
uppsala, sweden. choy.angel@gmail.com.
(13)department medical biochemistry microbiology, uppsala university,
uppsala, sweden. gote.swedberg@imbim.uu.se.

background: plasmodium falciparum resistance anti-malarials major
drawback effective malaria control elimination globally.
artemisinin-combination therapy (act) currently key first-line treatment
for uncomplicated falciparum malaria. plasmodium falciparum genetic signatures at
pfmdr-1, pfcrt, pfubp-1 loci known modulate vivo vitro
parasite response act. objective study assess the
distribution resistance gene markers isolates collected from
different malaria transmission intensity ethiopia tanzania.
methods: plasmodium falciparum clinical isolates collected different
regions ethiopia tanzania. genetic polymorphisms genes pfcrt,
pfmdr-1 pfubp-1 analysed pcr sequencing. frequencies the
different alleles three genes compared within regions,
and two countries.
results: majority isolates ethiopia mutant pfcrt 76 
and wild-type pfmdr-1 86. contrast, majority tanzanian samples 
were wild-type pfcrt pfmdr-1 loci. analysis variable linker
region pfmdr-1 showed substantial variation isolates tanzania as
compared ethiopian isolates minimal variation. direct sequencing of
the pfubp-1 region showed 92.8% (26/28) ethiopian isolates had
identical genome sequence wild type reference p. falciparum strain 3d7. 
of 42 isolates tanzania, 13 (30.9%) identical genome sequences with
3d7. tanzanian samples, 10 variant haplotypes identified.
conclusion: majority ethiopian isolates carried main marker for
chloroquine (cq) resistance, majority samples tanzania
carried markers cq susceptibility. polymorphic genes showed substantially
more variation tanzanian isolates. low variability polymorphic
region pfmdr-1 ethiopia may consequence low transmission intensity 
as compared high transmission intensity large variations tanzania.

doi: 10.1186/s12936-015-0783-3 
pmcid: pmc4495614
pmid: 26152336  [indexed medline]

